Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > From 86% (then 76%) to 46.2% ORR in PDL1+
View:
Post by Breakthorough1 on Aug 14, 2023 12:14am

From 86% (then 76%) to 46.2% ORR in PDL1+

That's a good drop since the ASH 2020 disclosed data till the 2023 publication of SPiReL results...

  https://onlinelibrary.wiley.com/doi/10.1111/ejh.13982
Comment by Breakthorough1 on Aug 14, 2023 4:13am
The OS is very good though: 10,1 months ITT; 17,4 months PDL1+. And with justification of MOA: 24,2 months in those patients with ELISpPlot response tu survivin; 24, 2 months in those with injection-site reaction (meaning DPX activity). The OS is better than that of Loncatusimab even in the ITT population (9'5 months for Lonca), and with bettter safety profile. The need for time (=money) has ...more  
IMV Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities